Medivis, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Medivis, Inc. - overview
Established
2016
Location
Brooklyn, NY, US
Primary Industry
Healthcare IT
About
Medivis, Inc. is a technology company focused on enhancing surgical visualization through innovative augmented reality solutions, aiming to improve surgical outcomes and efficiency for healthcare providers. Founded in 2016 and headquartered in Brooklyn, US, Medivis, Inc. develops advanced visualization technologies for surgical applications.
The company has completed five notable deals, with its most recent funding round occurring on June 13, 2023. Medivis secured USD 20. 00 mn in Series A funding, led by Thrive Capital, with participation from Coalition Operators, Initialized Capital, Mayo Clinic Ventures, and Thirty5 Ventures. The founders, Christopher Morley and Osamah Choudhry, are both instrumental in guiding the company's vision and growth, with Osamah Choudhry serving as the CEO.
Medivis specializes in advanced surgical visualization solutions, primarily through its flagship product, SurgicalAR, which transforms complex 2D imaging data into high-fidelity 3D visualizations. The company also offers FDA-cleared Spine Navigation solutions for open and minimally invasive surgeries, while developing Cranial Navigation and Prostate Navigation systems. With deployments exceeding 40 institutions across North America and Europe, Medivis provides essential tools for enhancing surgical planning and execution. Medivis' revenue model is based on B2B relationships with healthcare institutions.
The company generates income through direct sales and partnerships, deploying products like the Medivis PRO for operating rooms and the portable Medivis CORE for ICUs and clinics. Pricing structures are tailored to each deployment, ensuring hospitals and medical schools have the necessary support and ongoing updates for their systems. In June 2023, Medivis raised USD 20 mn in Series A funding, which will be utilized to advance engineering efforts, secure regulatory clearances, and support international commercialization across various medical specialties. The company aims to release new products, including additional navigation solutions, while expanding its market presence into new regions by focusing on strategic partnerships and innovative product offerings.
Current Investors
Initialized Capital, Arkitekt Ventures, Mayo Clinic Ventures
Primary Industry
Healthcare IT
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Healthcare IT, Surgical Devices, Multimedia & Graphics, Medical Software
Website
www.medivis.com
Verticals
Artificial Intelligence, Augmented Reality (AR)
Company Stage
Series A
Total Amount Raised
Subscriber access only
Medivis, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.